Gelteq is trading at $0.52, up +6.56%, with no company-specific announcement dated October 29 identified.

  • Gelteq’s investor-relations page lists June 17 as its latest release.
  • An October 28 update attributed the prior session’s gain to broader biotech strength, not a new company catalyst.
  • Supplied pre-market indicators are mixed and do not establish a clear broader-market reason for this move; pre-market trading activity and volume were unavailable in the reviewed sources.